IRIS
CILIBERTO, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.787
AS - Asia 2.703
EU - Europa 1.994
SA - Sud America 341
AF - Africa 46
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 17
Totale 11.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.530
SG - Singapore 1.848
IT - Italia 808
CN - Cina 483
SE - Svezia 414
GB - Regno Unito 368
BR - Brasile 300
CA - Canada 213
DE - Germania 160
IN - India 91
HK - Hong Kong 67
BD - Bangladesh 42
FI - Finlandia 42
JP - Giappone 32
NL - Olanda 32
VN - Vietnam 29
PL - Polonia 28
MX - Messico 27
UA - Ucraina 22
ES - Italia 21
IQ - Iraq 19
ZA - Sudafrica 19
SA - Arabia Saudita 18
CL - Cile 17
RO - Romania 17
AU - Australia 14
RU - Federazione Russa 13
TR - Turchia 13
EU - Europa 12
IR - Iran 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 9
PK - Pakistan 9
AR - Argentina 8
FR - Francia 8
AT - Austria 7
GR - Grecia 7
KE - Kenya 7
MA - Marocco 7
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
NZ - Nuova Zelanda 6
VE - Venezuela 6
IE - Irlanda 5
LT - Lituania 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
CH - Svizzera 4
DZ - Algeria 4
EE - Estonia 4
AL - Albania 3
EG - Egitto 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
HN - Honduras 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
TN - Tunisia 2
AO - Angola 1
BN - Brunei Darussalam 1
CG - Congo 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
RW - Ruanda 1
SN - Senegal 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.908
Salva come PNG Salva come JPEG
Città #
Chandler 1.195
Singapore 644
Santa Clara 581
Milan 511
Princeton 499
Lawrence 495
Chicago 322
London 299
Wilmington 295
Ottawa 165
Des Moines 152
Boardman 136
Munich 122
Ashburn 117
Hong Kong 64
Shanghai 61
Los Angeles 57
Guangzhou 46
Council Bluffs 45
Norwalk 42
Rome 42
Pune 41
Beijing 39
New York 38
Catanzaro 34
The Dalles 34
Turku 32
San Francisco 29
São Paulo 29
Brooklyn 28
Columbus 25
Redmond 23
Tokyo 23
Redwood City 22
Wuhan 22
Boston 20
Naples 20
Warsaw 20
Montreal 18
Assago 16
Atlanta 16
Shenzhen 16
Dallas 15
Falls Church 15
Stockholm 14
Washington 14
Phoenix 13
Charlotte 12
Dhaka 12
Johannesburg 12
Mexico City 12
Wuxi 12
Ann Arbor 11
Chennai 11
Rio de Janeiro 11
Rui'an 11
Amsterdam 10
Helsinki 10
Ho Chi Minh City 10
Jinan 9
Raleigh 9
Seattle 9
Toronto 9
Clearwater 8
Hanoi 8
Horia 8
Mountain View 8
Secaucus 8
West Jordan 8
Hanover 7
Las Vegas 7
Manchester 7
Amman 6
Augusta 6
Baghdad 6
Birmingham 6
Brasília 6
Dammam 6
Dongyang 6
Istanbul 6
Jiaxing 6
Miami 6
Nairobi 6
Olomouc 6
Riyadh 6
Viterbo 6
Belo Horizonte 5
Curitiba 5
Hefei 5
Houston 5
Jeddah 5
Kingston 5
Madrid 5
Napoli 5
Nuremberg 5
Parenti 5
Philadelphia 5
Ponta Grossa 5
Salvador 5
San Nicola Manfredi 5
Totale 6.899
Salva come PNG Salva come JPEG
Nome #
The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2 64
Monitoring of melanoma clinical progression by circulating NK and T cells immunoprofiling: a potential role for CCR7 in metastatic spread 59
Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition. 57
59. Structural characterization of a biologically active human Lipocortin 1 expressed in Escherichia coli 53
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells 50
A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and non-hepatic origin 48
A prokaryotic tRNA Tyr gene,inactive in Xenpous Laevis oocytes, is activated by recombination with an eukaryotic tRNA Pro gene 48
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro 47
Liver failure and defective hepatocyte regeneration in Interleukin-6 deficient mice 47
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study 47
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 46
Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs 45
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 45
MicroRNAs regulate resistance to target therapy in melanoma 44
A novel minigene scaffold for therapeutic cancer vaccines 44
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system 43
Analysis of T and Natural Killer cells immune response in Ipilimumab treated 43
A fast and sensitive colorimetric assay for IL-6 on hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP) 42
A novel method for site-directed mutagenesis: its application to an eukaryotic tRNAPro gene promoter 42
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 42
A functionally orthogonal estrogen Receptor-based transcription switch Tightly controlled by a non-steroid synthetic ligand 42
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines 41
Adenovirus-mediated gene transfer of a human IL-6 antagonist 41
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 41
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer 41
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 40
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice 40
miR-579-3p controls melanoma progression and resistance to target therapy 40
Inhibition of Stearoyl-Coa desaturase 1 (SCD1) enzymatic activity reverts BRAFi and MEKi-induced selection of cancer stem cells in BRAF-mutated malignant melanoma 40
PROGRESS AND PROSPECTS: TRANSCRIPTION REGULATORY SYSTEMS 39
DNA sequence of a pseudogene for human C-reactive protein 39
Leptin receptor-mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin 38
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 38
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope 38
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 37
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses 37
Monovalent phage display of human Interleukin (hIL)-6: selection superbinder variants for a complex molecular repertoire in hIL-6 D-Helix 37
Intratumor RNA interference of cell cycle genes slows down tumor progression 37
Liver-Specific –Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis 37
Epigenetic Changes Induced by Green Tea Catechins are Associated with Prostate Cancer 37
CD8+ T CELL TOLERANCE CAN BE BROKEN BY AN ADENOVIRUS VACCINE WHILE CD4+ T CELL TOLERANCE IS BROKEN BY ADDITIONAL CO-ADMINISTRATION OF A TOLL-LIKE RECEPTOR LIGAND 36
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients 36
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 36
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth 35
Interleukin-6 receptor antagonists inhibit IL-11 biological activity 35
Deducing the functional characteristics of the human selenoprotein SELK from the structural properties of its intrinsically disordered C-terminal domain 35
Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy 35
T-CELL PEPTIDE EPITOPES FROM CARCINOEMBRYONIC ANTIGEN, IMMUNOGENIC ANALOGS, AND USES THEREOF 35
A Multimeric Synthetic Combinatorial peptide library. A Multimeric Synthetic Combinatorial peptide library 35
The molecular design of human IL-6 receptor antagonists 34
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 34
Interleukin 6 deficient mice are protected from bone loss caused by estrogen depletion 34
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 34
IL-6 is required for airway mucus production induced by inhaled fungal allergens 33
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 33
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy? 33
ANALYSIS OF THE HIV-A GP41 SPECIFIC IMMUNE RESPONSE USING A MULTIPLEXED ANTIBODY DETECTION ASSAY 33
Kinesin spindle protein SiRNA slows down tumor progression 33
Phenotype characterization of human melanoma cells resistant to dabrafenib 33
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 33
B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells 33
Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer 32
Elevated levels of Interleukin-6 in unstable Angina 32
Electro-gene-transfer as a new tool for cancer immunotherapy in animals 32
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale" (vol 7, 287, 2016) 32
Enhanced inflammatory response to coronary angioplasty in patients with unstable angina 32
Generation of IL-6 antagonists by substituting residues in helix A 32
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 32
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 31
Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration 31
Synthetic peptide vaccines: The quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease 31
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas 31
Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors 31
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer 31
Processing of eukaryotic tRNA precursors: secondary structure of the precursor specific sequences affects the rate but not the accuracy of processing reactions 31
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models. 31
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure 31
Electro-gene-transfer: a new approach for muscle gene delivery 31
Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data 31
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells 31
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016 31
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation 31
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth 31
Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer 30
miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma 30
ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms 30
Loss of heterozygosity of imprented genes in SV40 t/T antigen-induced hepatocellular carcinomas 30
Inhibition of eukaryotic tRNA transcription by potential Z-DNA sequences 30
Saturation mutagenesis of the human Interleukin 6 receptor binding site: implications for its three-dimensional structure 30
Increased Toxin-Induced Liver Injury and Fibrosis in Interleukin-6-Deficient Mice 30
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 30
Alliance Against Cancer, the network of Italian cancer centers bridging research and care. 30
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine 30
Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. 30
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma 30
Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers of immune response 30
Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding 30
Tumor biobanks in translational medicine 30
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 30
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 30
Totale 3.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 12 7 7 20 7 45 23 41 26 4 18
2021/20221.332 20 5 9 316 114 27 60 287 119 153 211 11
2022/20233.544 1.002 62 32 348 446 333 1 259 605 201 212 43
2023/20241.420 349 215 129 79 63 380 49 22 16 24 43 51
2024/20254.729 788 408 184 150 173 601 76 197 702 255 303 892
2025/2026693 446 247 0 0 0 0 0 0 0 0 0 0
Totale 12.231